−4.2208USD
−5.46 MUSD
8.56 KUSD
1.73 M
About Virax Biolabs Group Limited
Sector
Industry
CEO
James Foster
Website
Headquarters
London
Employees (FY)
11
Founded
2013
FIGI
BBG0166WT3L7
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VRAX is 0.6900 USD — it has decreased by 1.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Virax Biolabs Group Limited stocks are traded under the ticker VRAX.
VRAX stock is 10.24% volatile and has beta coefficient of 1.87. Check out the list of the most volatile stocks — is Virax Biolabs Group Limited there?
Yes, you can track Virax Biolabs Group Limited financials in yearly and quarterly reports right on TradingView.
VRAX stock has fallen by 6.63% compared to the previous week, the month change is a 8.12% fall, over the last year Virax Biolabs Group Limited has showed a 85.00% decrease.
VRAX net income for the last quarter is −2.91 M USD, while the quarter before that showed −4.01 M USD of net income which accounts for 27.51% change. Track more Virax Biolabs Group Limited financial stats to get the full picture.
No, VRAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VRAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Virax Biolabs Group Limited stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 11.00 employees. See our rating of the largest employees — is Virax Biolabs Group Limited on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Virax Biolabs Group Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Virax Biolabs Group Limited stock shows the sell signal. See more of Virax Biolabs Group Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Virax Biolabs Group Limited EBITDA is −6.98 M USD, and current EBITDA margin is −66.96 K%. See more stats in Virax Biolabs Group Limited financial statements.